These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9081298)
1. Plants as bioreactors for biopharmaceuticals: regulatory considerations. Miele L Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298 [TBL] [Abstract][Full Text] [Related]
2. Biopharmaceuticals derived from genetically modified plants. Goldstein DA; Thomas JA QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527 [TBL] [Abstract][Full Text] [Related]
3. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Hefferon KL Virology; 2012 Nov; 433(1):1-6. PubMed ID: 22979981 [TBL] [Abstract][Full Text] [Related]
4. Plant-derived vaccines and other therapeutics produced in contained systems. Franconi R; Demurtas OC; Massa S Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011 [TBL] [Abstract][Full Text] [Related]
5. Plant-based production of xenogenic proteins. Hood EE; Jilka JM Curr Opin Biotechnol; 1999 Aug; 10(4):382-6. PubMed ID: 10449314 [TBL] [Abstract][Full Text] [Related]
7. Transgenic plants as factories for biopharmaceuticals. Giddings G; Allison G; Brooks D; Carter A Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432 [TBL] [Abstract][Full Text] [Related]
8. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots. Sivakumar G Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730 [TBL] [Abstract][Full Text] [Related]
9. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Daniell H; Streatfield SJ; Wycoff K Trends Plant Sci; 2001 May; 6(5):219-26. PubMed ID: 11335175 [TBL] [Abstract][Full Text] [Related]
10. An FDA perspective of manufacturing changes for products in human use. Durfor CN; Scribner CL Ann N Y Acad Sci; 1992 Oct; 665():356-63. PubMed ID: 1416614 [No Abstract] [Full Text] [Related]
11. Growing pains for biopharmaceuticals. Ashton G Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578 [No Abstract] [Full Text] [Related]
12. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
17. Approval times for supplemental indications for recombinant proteins. Gosse ME; Nelson TF Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135 [No Abstract] [Full Text] [Related]
18. Plant biopharming of monoclonal antibodies. Ko K; Koprowski H Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408 [TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
20. Competitive bioreactor hens on the horizon. Ivarie R Trends Biotechnol; 2006 Mar; 24(3):99-101. PubMed ID: 16445998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]